Eric Morgen
CIK 2036289 · View on SEC EDGAR ↗
First SEC filing: Sept. 25, 2024 · Latest: Sept. 25, 2024
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 18, 2025 | BIOA | A | 25,000 | — | — | 25,000 Indirect | — | Acquired | (price as of 2026-08-24) |
| Feb. 18, 2025 | BIOA | A | 200,000 | — | — | 200,000 Direct | — | Acquired | (price as of 2026-08-24) |
| Sept. 25, 2024 | BIOA | A | 4,952 | — | — | 4,952 Indirect | — | Acquired | (price as of 2026-08-24) |
| April 17, 2024 | BIOA | A | 257,973 | — | — | 257,973 Direct | — | Acquired | (price as of 2026-08-24) |
| April 17, 2024 | BIOA | A | 13,598 | — | — | 13,598 Indirect | — | Acquired | (price as of 2026-08-24) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 18, 2025 | BIOA | Stock Option (Right to Buy) | Common Stock (25,000) | $4.38 | Feb. 17, 2035 | 25,000 | Acquired |
| Feb. 18, 2025 | BIOA | Stock Option (Right to Buy) | Common Stock (200,000) | $4.38 | Feb. 17, 2035 | 200,000 | Acquired |
| Sept. 25, 2024 | BIOA | Stock Option (Right to Buy) | Common Stock (4,952) | $18.00 | Sept. 24, 2034 | 4,952 | Acquired |
| April 17, 2024 | BIOA | Stock Option (Right to Buy) | Common Stock (257,973) | $8.39 | April 16, 2034 | 257,973 | Acquired |
| April 17, 2024 | BIOA | Stock Option (Right to Buy) | Common Stock (13,598) | $8.39 | April 16, 2034 | 13,598 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 12 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Sept. 25, 2024 | BIOA | Common Stock | 67,225 | Direct |
| Sept. 25, 2024 | BIOA | Stock Option (Right to Buy)→ Common Stock (79,399) | 79,399 | Direct |
| Sept. 25, 2024 | BIOA | Stock Option (Right to Buy)→ Common Stock (92,815) | 92,815 | Direct |
| Sept. 25, 2024 | BIOA | Stock Option (Right to Buy)→ Common Stock (42,867) | 42,867 | Direct |
| Sept. 25, 2024 | BIOA | Stock Option (Right to Buy)→ Common Stock (42,867) | 42,867 | Direct |
| Sept. 25, 2024 | BIOA | Stock Option (Right to Buy)→ Common Stock (257,973) | 257,973 | Direct |
| Sept. 25, 2024 | BIOA | Stock Option (Right to Buy)→ Common Stock (1,233) | 1,233 | Indirect |
| Sept. 25, 2024 | BIOA | Stock Option (Right to Buy)→ Common Stock (493) | 493 | Indirect |
| Sept. 25, 2024 | BIOA | Stock Option (Right to Buy)→ Common Stock (6,274) | 6,274 | Indirect |
| Sept. 25, 2024 | BIOA | Stock Option (Right to Buy)→ Common Stock (2,464) | 2,464 | Indirect |
| Sept. 25, 2024 | BIOA | Stock Option (Right to Buy)→ Common Stock (2,464) | 2,464 | Indirect |
| Sept. 25, 2024 | BIOA | Stock Option (Right to Buy)→ Common Stock (13,598) | 13,598 | Indirect |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
BIOA
COO| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $499,600 | — | — | — | $199,840 | — | $15,200 | $1,447,240 |
| 2024 | $457,657 | — | — | — | $160,180 | — | $15,000 | $2,465,347 |
| 2023 | $435,686 | — | — | — | $190,613 | — | $14,400 | $872,798 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.